Epoxomicin
Cat.No:IE1040 Solarbio
CAS:134381-21-8
Molecular Formula:C28H50N4O7
Molecular Weight:554.72
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Metabolic Enzyme & Protease >
EpoxomicinCAS:134381-21-8
Molecular Formula:C28H50N4O7
Molecular Weight:554.72
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 134381-21-8 |
Name | Epoxomicin |
Molecular Formula | C28H50N4O7 |
Molecular Weight | 554.72 |
Solubility | Soluble in DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD03791061 |
SMILES | CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)[C@]1(CO1)C)NC(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C |
InChIKey | DOGIDQKFVLKMLQ-JTHVHQAWSA-N |
InChI | InChI=1S/C28H50N4O7/c1-11-16(5)21(30-27(38)23(17(6)12-2)32(10)19(8)34)25(36)31-22(18(7)33)26(37)29-20(13-15(3)4)24(35)28(9)14-39-28/h15-18,20-23,33H,11-14H2,1-10H3,(H,29,37)(H,30,38)(H,31,36)/t16-,17-,18+,20-,21-,22-,23-,28+/m0/s1 |
PubChem CID | 11226684 |
Target Point | Proteasome |
Passage | Metabolic Enzyme&Protease |
Background | It is a potent, selective and irreversible proteasome inhibitor. |
Biological Activity | Epoxomicin 是一种含环氧酮的天然产物,也是一种强效、选择性和不可逆的蛋白酶体抑制剂。能与蛋白酶体的 LMP7、X、MECL1 和 Z 催化亚基共价结合,主要抑制糜蛋白酶样活性,可穿过血脑屏障,具有很强的抗肿瘤和抗炎活性。[1-5] |
Data Literature Source | [1]. Hanada M,et al. Epoxomicin,a new antitumor agent of microbial origin. J Antibiot (Tokyo). 1992 Nov;45(11): 1746-52. [2]. Kim KB,et al. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Bioorg Med Chem Lett. 1999 Dec 6;9(23): 3335-40. [3]. Meng L,et al. Epoxomicin,a potent and selective proteasome inhibitor,exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18): 10403-8. [4]. Garrett IR,et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest. 2003 Jun;111(11): 1771-82. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.